Skip to main content
. 2012 Aug 3;7(8):e42407. doi: 10.1371/journal.pone.0042407

Table 3. Comparison of effect sizes of CEU-identified variants for CRC across CEU and three different Chinese populations.

CEU# NCH? HK-CH& SCH
Chr iSNP OR (95% CI) iSNP OR (95% CI) iSNP/sSNP OR (95% CI) iSNP/sSNP OR (95% CI)
1q41 rs6687758 1.09 (1.06, 1.12)* rs6695584 1.16 (0.98, 1.36)*
3q26.2 rs10936599 0.93 (0.91, 0.96)* rs12638862 0.98 (0.87, 1.12)
8q23.3 rs16892766 1.25 (1.19, 1.32)* rs16892766 NP rs11986063 1.40 (1.04, 1.89)*
8q24.21 rs6983267 1.27 (1.16, 1.39)* rs6983267 1.23 (1.13–1.34)* rs7014346 1.23 (1.05–1.44)* rs6983267 1.15 (1.00, 1.31)*
10p14 rs10795668 0.89 (0.86, 0.91)* rs10795668 1.23 (1.12–1.34)** rs10795668 1.28 (1.1–1.5)* rs827401 0.74 (0.63, 0.88)**
11q23.1 rs3802842 1.11 (1.08, 1.15)* rs3802842 1.29 (1.18–1.40)* rs3802842 1.10 (0.95–1.27) rs3087967 1.22 (1.07, 1.38)*
12q13.13 rs7136702 1.06 (1.04–1.08)* rs7136702 1.08 (0.95, 1.22)
14q22 rs4444235 1.11 (1.08–1.15)* rs4444235 1.08 (0.99–1.18) rs4444235 1.02 (0.88–1.18) rs4444235 NS
15q13.3 rs4779584 1.23 (1.14, 1.34)* rs4779584 1.02 (0.92–1.13) rs4779584 1.26 (1.04–1.52)* rs4779584 1.14 (0.94, 1.38)
16q22.1 rs9929218 0.91 (0.89, 0.94)* rs9929218 1.09 (0.97–1.23) rs9929218 1.00 (0.84–1.18) rs2059254 0.86 (0.73, 1.00)*
18q21.1 rs4939827 1.18 (1.12, 1.23)* rs4939827 1.17 (1.05–1.31)* rs4939827 1.17 (1.01–1.37)* rs7226855 1.13 (0.99, 1.28)*
19q13.1 rs10411210 1.15 (1.10–1.20)* rs10411210 1.10 (0.99–1.22) rs10411210 1.02 (0.85–1.24) rs10411210 NS
20p12.3 rs961253 1.12 (1.08, 1.16)* rs961253 1.37 (1.19–1.59)* rs355527 1.10 (0.84–1.45) rs5005940 1.00 (0.79, 1.28)
20q13.33 rs4925386 0.93 (0.91,0.95)* rs4925386 NS
#

CEU SNP reference sources: as reported in the GWAS catalogue for CRC: http://www.genome.gov/gwastudies/index.cfm?pageid=26525384#searchForm.

?Northern Chinese (reference 5); &Hong Kong Chinese (reference 6); NP =  non-polymorphic; NS =  no surrogate SNP at high LD within 100 kb of iSNP; empty cell  =  SNP not interrogated; *show evidence of being associated with CRC risk; **show evidence of being associated with rectal cancer risk.